GENERATION BIO CO. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/412a7c48-7cac-4189-b626-bc6ff8f9c68b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-142.4M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002907 |
| FY 2023 | $-138.6M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002616 |
| FY 2022 | $-141.2M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-001916 |
| FY 2021 | $-119.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-001957 |
| FY 2020 | $-81.1M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-085043 |
| FY 2019 | $-62.3M | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-085043 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).